<p>Weighted mean difference in changes in FPG for AGI treatment versus placebo in Caucasian.</p
Differences in observables between attritors and non-attritors across treatment groups.</p
(A) Mean weight (kg). (B) Mean mid-upper arm circumference (cm). (C) Mean head circumference (cm). (...
<p>Comparison of changes in hemoglobin A1c values between the placebo and metformin groups during th...
<p>Weighted mean difference in changes in FPG for AGI treatment versus placebo or active control in ...
<p>Weighted mean difference in change in HbA1c for AGI treatment versus placebo in Caucasian.</p
<p>Weighted mean difference in change in HbA1c for AGI treatment versus placebo or active control in...
<p>Comparisons between Asian and Caucasian in the WMD in changes of efficacy of AGI treatment versus...
<p>Forest plot of weighted mean difference in severity of HAH using VAS in placebo and ibuprofen gro...
<p>Funnel plot for mean difference (MD) in the change in HbA1c (DPP-4 inhibitor vs. placebo or no tr...
<p>Weighted differences (with 95% CI) of mean serum [Na<sup>+</sup>] in dead and alive patients.</p
*<p>For comparisons of treatment A versus treatment B, statistically significant results are shown, ...
Baseline characteristics of the patients in the aleglitazar group compared with the placebo group.</...
<p>Weighted mean difference or odds ratio (95% confidence intervals) of three treatment modalities o...
<p>All variables are presented as mean ± standard deviation.</p><p><b>Δ:</b> difference between base...
<p>The mean difference in weight change by intervention group for BMI categories.</p
Differences in observables between attritors and non-attritors across treatment groups.</p
(A) Mean weight (kg). (B) Mean mid-upper arm circumference (cm). (C) Mean head circumference (cm). (...
<p>Comparison of changes in hemoglobin A1c values between the placebo and metformin groups during th...
<p>Weighted mean difference in changes in FPG for AGI treatment versus placebo or active control in ...
<p>Weighted mean difference in change in HbA1c for AGI treatment versus placebo in Caucasian.</p
<p>Weighted mean difference in change in HbA1c for AGI treatment versus placebo or active control in...
<p>Comparisons between Asian and Caucasian in the WMD in changes of efficacy of AGI treatment versus...
<p>Forest plot of weighted mean difference in severity of HAH using VAS in placebo and ibuprofen gro...
<p>Funnel plot for mean difference (MD) in the change in HbA1c (DPP-4 inhibitor vs. placebo or no tr...
<p>Weighted differences (with 95% CI) of mean serum [Na<sup>+</sup>] in dead and alive patients.</p
*<p>For comparisons of treatment A versus treatment B, statistically significant results are shown, ...
Baseline characteristics of the patients in the aleglitazar group compared with the placebo group.</...
<p>Weighted mean difference or odds ratio (95% confidence intervals) of three treatment modalities o...
<p>All variables are presented as mean ± standard deviation.</p><p><b>Δ:</b> difference between base...
<p>The mean difference in weight change by intervention group for BMI categories.</p
Differences in observables between attritors and non-attritors across treatment groups.</p
(A) Mean weight (kg). (B) Mean mid-upper arm circumference (cm). (C) Mean head circumference (cm). (...
<p>Comparison of changes in hemoglobin A1c values between the placebo and metformin groups during th...
DOI
Add to ORKG